Team:Tokyo Tech/safety
From 2010.igem.org
Line 25: | Line 25: | ||
A、 Just in case, we refereed papers for our new biobrick parts. | A、 Just in case, we refereed papers for our new biobrick parts. | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
</div> <!-- end SubWrapper --> | </div> <!-- end SubWrapper --> |
Revision as of 07:23, 16 October 2010
Q&A
For iGEM 2010 teams are asked to detail how they approached any issues of biological safety associated with their projects. Specifically, teams should consider the following four questions:
Would any of your project ideas raise safety issues in terms of: researcher safety, public safety, or environmental safety?
Q、 Is there a local biosafety group, committee, or review board at your institution?
A、 Biosafety committee of our organization accepted our aplications.
Q、 What does your local biosafety group think about your project?
A、 They think our project is leagal.
Q、 Do any of the new BioBrick parts that you made this year raise any safety issues?
A、 No. Our parts are safty level one. We used genes which are analysed in peer-reviewed papers.
Q、 If yes, did you document these issues in the Registry?
A、 Just in case, we refereed papers for our new biobrick parts.
</body></html>